Hyaluronate Sodium
691 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
691
Total Reports
18
Deaths Reported
260.0%
Death Rate
Active Ingredients
Hyaluronate Sodium
Administration Routes
UnknownIntra-ArticularIntravenousIntramuscularOtherOphthalmicParenteralIntraocularTopicalAuricular (Otic)
Species Affected
Unknown 422
Horse 255
Dog 10
Human 2
Cat 1
Rabbit 1
Most Affected Breeds
Unknown 480
Quarter Horse 51
Horse (unknown) 48
Warmblood (unspecified) 19
Thoroughbred 18
Warmblood - Dutch 8
Horse (other) 8
Arab 6
Paint 6
Standardbred (unspecified) 5
Most Reported Reactions
Stopper, abnormal 101
Syringe, Abnormal 96
Lameness 73
Product syringe issue 71
Uncoded sign 64
Illness NOS 46
No sign 32
Joint swelling 23
Synovitis 21
Injection site swelling 21
Containers, Leaking 21
Seal, Abnormal 20
Outcome Breakdown
Recovered/Normal
108 (44.6%)
Outcome Unknown
79 (32.6%)
Ongoing
34 (14.0%)
Died
11 (4.5%)
Euthanized
7 (2.9%)
Recovered with Sequela
3 (1.2%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.